Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Miguel Beato

Showing results (81-90 of 89) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 89 results.
Cellular and Molecular Life Sciences : CMLS|February 22, 2024
A progesterone derivative linked to a stable phospholipid activates breast cancer cell response without leaving the cell membraneJofre Font-Mateu, Pol Sanllehí, Jesús Sot, et al.
Nature Genetics|January 17, 2018
Transcription factors orchestrate dynamic interplay between genome topology and gene regulation during cell reprogrammingRalph Stadhouders, Enrique Vidal, François Serra, et al.
Molecular Cell|November 25, 2019
TFIIIC Binding to Alu Elements Controls Gene Expression via Chromatin Looping and Histone AcetylationRoberto Ferrari, Lara Isabel de Llobet Cucalon, Chiara Di Vona, et al.
Elife|January 12, 2022
Chromatin topology defines estradiol-primed progesterone receptor and PAX2 binding in endometrial cancer cellsAlejandro La Greca, Nicolás Bellora, François Le Dily, et al.
The EMBO Journal|April 2, 2024
LATS1 controls CTCF chromatin occupancy and hormonal response of 3D-grown breast cancer cellsJulieta Ramírez-Cuéllar, Roberto Ferrari, Rosario T Sanz, et al.
Genome Research|December 16, 2018
Hormone-control regions mediate steroid receptor-dependent genome organizationFrançois Le Dily, Enrique Vidal, Yasmina Cuartero, et al.
Science (New York, N.Y.)|June 4, 2016
ADP-ribose-derived nuclear ATP synthesis by NUDIX5 is required for chromatin remodelingRoni H G Wright, Antonios Lioutas, Francois Le Dily, et al.
Nature Communications|January 19, 2018
Targeted NUDT5 inhibitors block hormone signaling in breast cancer cellsBrent D G Page, Nicholas C K Valerie, Roni H G Wright, et al.
Nature Communications|November 3, 2019
Author Correction: Targeted NUDT5 inhibitors block hormone signaling in breast cancer cellsBrent D G Page, Nicholas C K Valerie, Roni H G Wright, et al.
Pageof 9

Showing results (81-90 of 89) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 89 results.
Cellular and Molecular Life Sciences : CMLS|February 22, 2024
A progesterone derivative linked to a stable phospholipid activates breast cancer cell response without leaving the cell membraneJofre Font-Mateu, Pol Sanllehí, Jesús Sot, et al.
Nature Genetics|January 17, 2018
Transcription factors orchestrate dynamic interplay between genome topology and gene regulation during cell reprogrammingRalph Stadhouders, Enrique Vidal, François Serra, et al.
Molecular Cell|November 25, 2019
TFIIIC Binding to Alu Elements Controls Gene Expression via Chromatin Looping and Histone AcetylationRoberto Ferrari, Lara Isabel de Llobet Cucalon, Chiara Di Vona, et al.
Elife|January 12, 2022
Chromatin topology defines estradiol-primed progesterone receptor and PAX2 binding in endometrial cancer cellsAlejandro La Greca, Nicolás Bellora, François Le Dily, et al.
The EMBO Journal|April 2, 2024
LATS1 controls CTCF chromatin occupancy and hormonal response of 3D-grown breast cancer cellsJulieta Ramírez-Cuéllar, Roberto Ferrari, Rosario T Sanz, et al.
Genome Research|December 16, 2018
Hormone-control regions mediate steroid receptor-dependent genome organizationFrançois Le Dily, Enrique Vidal, Yasmina Cuartero, et al.
Science (New York, N.Y.)|June 4, 2016
ADP-ribose-derived nuclear ATP synthesis by NUDIX5 is required for chromatin remodelingRoni H G Wright, Antonios Lioutas, Francois Le Dily, et al.
Nature Communications|January 19, 2018
Targeted NUDT5 inhibitors block hormone signaling in breast cancer cellsBrent D G Page, Nicholas C K Valerie, Roni H G Wright, et al.
Nature Communications|November 3, 2019
Author Correction: Targeted NUDT5 inhibitors block hormone signaling in breast cancer cellsBrent D G Page, Nicholas C K Valerie, Roni H G Wright, et al.
Pageof 9